PerkinElmer Inc.
PerkinElmer Inc. of Wellesley, Mass.,
has purchased the assets of Spectral Genomics Inc., a molecular karyotyping technology
company in Houston. The acquisition includes products and analysis software that
enable researchers to evaluate chromosomal abnormalities related to the study of
cancer and pre- and postnatal genetic disorders. The Array CGH (comparative genome
hybridization) technology identifies the locations of chromosomal deletions and
amplifications that indicate an increased risk of genetic disease by providing a
high-resolution global view of the human genome. PerkinElmer will use the additions
to its product line to complement its molecular medicine and genetic screening offerings.
LATEST NEWS